Literature DB >> 20967299

Botulinum toxin type A: Exploring new indications.

A Brashear1.   

Abstract

The use of botulinum toxin has expanded in the last five years to include traditional neurological use against dystonia and spasticity, as well as the emerging use for headache, pain, neuropathy, myofascial pain, joint arthritis, otolaryngology, gastroenterology and genitourinary disorders. This review will focus on these emerging uses of botulinum toxin as reported in recent literature. The exploratory use of botulinum toxin for cervical dystonia, blepharospasm and spasticity in small trials and case reports, has led to its detailed study in larger placebo-controlled clinical trials. Although the use of botulinum toxin for new indications may benefit a specific subset of patients with refractory pain and disability, the reader must realize that this is an emerging area, generally limited by a lack of large, placebo-controlled studies. Copyright 2010 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967299     DOI: 10.1358/dot.2010.46.9.1524356

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  4 in total

Review 1.  Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence.

Authors:  Roberta Ravenni; Domenico De Grandis; Alberto Mazza
Journal:  Neurol Sci       Date:  2013-04-11       Impact factor: 3.307

2.  Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.

Authors:  Molly S Moritz; William H Tepp; Heather N'te Inzalaco; Eric A Johnson; Sabine Pellett
Journal:  Toxicon       Date:  2019-06-07       Impact factor: 3.033

3.  Botulinum toxin injections for blepharospasm prior to ocular surgeries.

Authors:  Seydi Okumus; Erol Coskun; Ibrahim Erbagci; M Gürkan Tatar; Aysegul Comez; Erdal Kaydu; Ramazan Yayuspayi; Bulent Gurler
Journal:  Clin Ophthalmol       Date:  2012-05-03

4.  Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative.

Authors:  Jacob M Scherf; Xiaoyang Serene Hu; William H Tepp; Konstantin Ichtchenko; Eric A Johnson; Sabine Pellett
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.